Get 40% Off
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March.Read full update

Plus Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying

Published 18/09/2023, 13:43
© Reuters.  Plus Therapeutics And 2 Other Stocks Under $2 Insiders Are Buying

Benzinga - by Lisa Levin, Benzinga Editor.

The Dow Jones closed lower by close to 300 points on Friday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading decision.

Below is a look at a few recent notable insider transactions for penny stocks. For more, check out Benzinga's insider transactions platform.

Plus Therapeutics

  • The Trade: Plus Therapeutics, Inc (NASDAQ: PSTV) Director Howard Clowes acquired a total of 6,993 shares an average price of $1.43. To acquire these shares, it cost around $10,022.
  • What’s Happening: Plus Therapeutics announced a licensing agreement with Biocept.
  • What Plus Therapeutics Does: Plus Therapeutics Inc is a clinical-stage pharmaceutical company. The company focused on the discovery, development, and delivery of complex and innovative treatments for patients battling cancer and rare diseases.
Blend Labs
  • The Trade: Blend Labs, Inc. (NYSE: BLND) Head of Finance and Admin. Amir Jafari acquired a total of 14,369 shares at an average price of $1.19. The insider spent around $17,125.
  • What’s Happening: Blend Labs reported better-than-expected second-quarter financial results and issued third-quarter consolidated revenue guidance.
  • What Blend Labs Does: Blend Labs Inc is a cloud-based platform software platform that powers the digital interface between financial services firms and consumers.
Bimini Capital Management
  • The Trade: Bimini Capital Management, Inc. (OTC: BMNM) CFO G. Hunter Haas IV acquired a total of 9,354 shares at an average price of $0.93. To acquire these shares, it cost around $8,694.
  • What’s Happening: The company posted second-quarter net income of $0.3 million, or 3 cents per share.
  • What Bimini Capital Management Does: Bimini Capital Management Inc is a specialty finance company that operates in two reportable segments, The asset management segment includes the investment advisory services provided by Bimini Advisors to Orchid and Royal Palm.
3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Check This Out: How To Earn $500 A Month From Apple After New iPhone Launch

Don’t forget to check out our premarket coverage here

© 2023 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.